9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Death place and palliative outcome indicators in patients under palliative home care service: an observational study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Dying at home accompanied by loved-ones is regarded favorably and brings good luck in Taiwan. This study aimed to examine the relevant factors affecting whether an individual dies at home or not in a group of terminal patients receiving palliative home care service.

          Methods

          The patients who were admitted to a palliative home care service at a hospital-affiliated home health care agency were consecutively enrolled between March 1, 2021 and March 31, 2022. During the period of care, the instruments of the palliative care outcomes collaboration was used to assess patients in each home visit twice a week, including symptom assessment scale, palliative care problem severity score, Australia-modified Karnofsky performance status, resource utilization groups-activities of daily living, and palliative care phase.

          Results

          There were 56 participants (53.6% female) with a median age of 73.0 years (interquartile range (IQR) 61.3–80.3 y/o), of whom 51 (91.1%) patients were diagnosed with cancer and 49 (96.1%) had metastasis. The number of home visits was 3.5 (IQR 2.0–5.0) and the average number of days under palliative home care service was 31 (IQR 16.3–51.5) before their death. After the end of the study, there was a significant deterioration of sleeping, appetite, and breathing problems in the home-death group, and appetite problems in the non-home death patients. However, physician-reported psychological/spiritual problems improved in the home-death group, and pain improved in the non-home death patients. Physical performance deteriorated in both groups, and more resource utilization of palliative care was needed. The 44 patients who died at home had greater cancer disease severity, fewer admissions, and the proportion of families desiring a home death for the patient was higher.

          Conclusions

          Although the differences in palliative outcome indicators were minor between patients who died at home and those who died in the hospital, understanding the determinants and change of indicators after palliative care service at different death places may be helpful for improving the quality of end-of-life care.

          Highlights

          • Hospice care is a type of palliative care that focuses on patients with advanced, life-limiting illnesses, and these terms are sometimes used interchangeably for patients who are in the last months or years of their life.

          • The number of patients finally dying at home was high in our palliative home service, and the congruence regarding place of death between patients and family, their preferred place of death, cancer with metastasis, and the hospital admission during palliative home care were associated with the actual place of death.

          • Psychological well-being and spirituality was more enhanced in home-death patients, and pain was improved in hospital-death patients.

          • Understanding the determinants and change of indicators during palliative care service at different death places may be helpful for improving the quality of end-of-life care.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Early palliative care for patients with metastatic non-small-cell lung cancer.

          Patients with metastatic non-small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the effect of introducing palliative care early after diagnosis on patient-reported outcomes and end-of-life care among ambulatory patients with newly diagnosed disease. We randomly assigned patients with newly diagnosed metastatic non-small-cell lung cancer to receive either early palliative care integrated with standard oncologic care or standard oncologic care alone. Quality of life and mood were assessed at baseline and at 12 weeks with the use of the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale and the Hospital Anxiety and Depression Scale, respectively. The primary outcome was the change in the quality of life at 12 weeks. Data on end-of-life care were collected from electronic medical records. Of the 151 patients who underwent randomization, 27 died by 12 weeks and 107 (86% of the remaining patients) completed assessments. Patients assigned to early palliative care had a better quality of life than did patients assigned to standard care (mean score on the FACT-L scale [in which scores range from 0 to 136, with higher scores indicating better quality of life], 98.0 vs. 91.5; P=0.03). In addition, fewer patients in the palliative care group than in the standard care group had depressive symptoms (16% vs. 38%, P=0.01). Despite the fact that fewer patients in the early palliative care group than in the standard care group received aggressive end-of-life care (33% vs. 54%, P=0.05), median survival was longer among patients receiving early palliative care (11.6 months vs. 8.9 months, P=0.02). Among patients with metastatic non-small-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival. (Funded by an American Society of Clinical Oncology Career Development Award and philanthropic gifts; ClinicalTrials.gov number, NCT01038271.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.

            Randomized controlled trials have supported integrated oncology and palliative care (PC); however, optimal timing has not been evaluated. We investigated the effect of early versus delayed PC on quality of life (QOL), symptom impact, mood, 1-year survival, and resource use.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial.

              Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early palliative care in patients with advanced cancer on several aspects of quality of life. The study took place at the Princess Margaret Cancer Centre (Toronto, ON, Canada), between Dec 1, 2006, and Feb 28, 2011. 24 medical oncology clinics were cluster randomised (in a 1:1 ratio, using a computer-generated sequence, stratified by clinic size and tumour site [four lung, eight gastrointestinal, four genitourinary, six breast, two gynaecological]), to consultation and follow-up (at least monthly) by a palliative care team or to standard cancer care. Complete masking of interventions was not possible; however, patients provided written informed consent to participate in their own study group, without being informed of the existence of another group. Eligible patients had advanced cancer, European Cooperative Oncology Group performance status of 0-2, and a clinical prognosis of 6-24 months. Quality of life (Functional Assessment of Chronic Illness Therapy--Spiritual Well-Being [FACIT-Sp] scale and Quality of Life at the End of Life [QUAL-E] scale), symptom severity (Edmonton Symptom Assessment System [ESAS]), satisfaction with care (FAMCARE-P16), and problems with medical interactions (Cancer Rehabilitation Evaluation System Medical Interaction Subscale [CARES-MIS]) were measured at baseline and monthly for 4 months. The primary outcome was change score for FACIT-Sp at 3 months. Secondary endpoints included change score for FACIT-Sp at 4 months and change scores for other scales at 3 and 4 months. This trial is registered with ClinicalTrials.gov, number NCT01248624. 461 patients completed baseline measures (228 intervention, 233 control); 393 completed at least one follow-up assessment. At 3-months, there was a non-significant difference in change score for FACIT-Sp between intervention and control groups (3·56 points [95% CI -0·27 to 7·40], p=0·07), a significant difference in QUAL-E (2·25 [0·01 to 4·49], p=0·05) and FAMCARE-P16 (3·79 [1·74 to 5·85], p=0·0003), and no difference in ESAS (-1·70 [-5·26 to 1·87], p=0·33) or CARES-MIS (-0·66 [-2·25 to 0·94], p=0·40). At 4 months, there were significant differences in change scores for all outcomes except CARES-MIS. All differences favoured the intervention group. Although the difference in quality of life was non-significant at the primary endpoint, this trial shows promising findings that support early palliative care for patients with advanced cancer. Canadian Cancer Society, Ontario Ministry of Health and Long Term Care. Copyright © 2014 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                sylin@vghtc.gov.tw
                hyhui@vghtc.gov.tw
                Journal
                BMC Palliat Care
                BMC Palliat Care
                BMC Palliative Care
                BioMed Central (London )
                1472-684X
                19 April 2023
                19 April 2023
                2023
                : 22
                : 44
                Affiliations
                [1 ]GRID grid.410764.0, ISNI 0000 0004 0573 0731, Home Health Care Agency, Taichung Veterans General Hospital, ; Taichung, 40705 Taiwan
                [2 ]GRID grid.410764.0, ISNI 0000 0004 0573 0731, Department of Nursing, , Taichung Veterans General Hospital, ; Taichung, 40705 Taiwan
                [3 ]GRID grid.410764.0, ISNI 0000 0004 0573 0731, Center for Geriatrics & Gerontology, , Taichung Veterans General Hospital, ; Taichung, 40705 Taiwan
                [4 ]GRID grid.410764.0, ISNI 0000 0004 0573 0731, Division of Occupational Medicine, Department of Emergency, , Taichung Veterans General Hospital, ; Taichung, 40705 Taiwan
                [5 ]GRID grid.260542.7, ISNI 0000 0004 0532 3749, Research Center for Geriatrics and Gerontology, College of Medicine, , National Chung Hsing University, ; Taichung, 40200 Taiwan
                [6 ]GRID grid.260542.7, ISNI 0000 0004 0532 3749, Department of Post-Baccalaureate Medicine, College of Medicine, , National Chung Hsing University, ; Taichung, 40200 Taiwan
                [7 ]GRID grid.410764.0, ISNI 0000 0004 0573 0731, Department of Family Medicine, , Taichung Veterans General Hospital, ; Taichung, 40705 Taiwan
                [8 ]GRID grid.410764.0, ISNI 0000 0004 0573 0731, Division of Endocrinology and Metabolism, Department of Internal Medicine, , Taichung Veterans General Hospital, ; Taichung, 40705 Taiwan
                [9 ]GRID grid.260539.b, ISNI 0000 0001 2059 7017, Institute of Clinical Medicine, School of Medicine, , National Yang Ming Chiao Tung University, ; Taipei, 11221 Taiwan
                Article
                1167
                10.1186/s12904-023-01167-8
                10114304
                37072784
                2ec28ac2-63db-4b76-8924-64c9d20f5b8f
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 10 November 2022
                : 4 April 2023
                Categories
                Research
                Custom metadata
                © The Author(s) 2023

                Anesthesiology & Pain management
                palliative care,hospice care,end-of-life,place of death
                Anesthesiology & Pain management
                palliative care, hospice care, end-of-life, place of death

                Comments

                Comment on this article